An IKKAα-E2F1-BMI1 cascade activated by infiltrating B cells controls prostate regeneration and tumor recurrence

Genes and Development

Volumn 27, Issue 13, 2013, Pages 1435-1440

  Ammirante, Massimo ^a   Kuraishy, Ali I ^a   Shalapour, Shabnam ^a   Strasner, Amy ^a   Ramirez Sanchez, Claudia ^a   Zhang, Weizhou ^a   Shabaik, Ahmed ^a   Karin, Michael ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

B cells; Prostate; Regeneration

Indexed keywords

BMI1 PROTEIN; I KAPPA B KINASE ALPHA; TRANSCRIPTION FACTOR E2F1; ANDROGEN; BMI1 PROTEIN, MOUSE; E2F1 PROTEIN, MOUSE; I KAPPA B KINASE; ONCOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CELL INFILTRATION; CELL PROLIFERATION; CONTROLLED STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; RECURRENT CANCER; REGENERATION; STEM CELL; WILD TYPE; ANIMAL; CELL CULTURE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; ORCHIECTOMY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSTATE; PROSTATE TUMOR; TUMOR RECURRENCE; B CELLS; DRUG EFFECT;

ANDROGENS; ANIMALS; B-LYMPHOCYTES; CELLS, CULTURED; E2F1 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; I-KAPPA B KINASE; MALE; MICE; NEOPLASM RECURRENCE, LOCAL; ORCHIECTOMY; POLYCOMB REPRESSIVE COMPLEX 1; PROSTATE; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS; REGENERATION;

B CELLS; PROSTATE; REGENERATION;

EID: 84879757412     PISSN: 08909369     EISSN: 15495477     Source Type: Journal    
DOI: 10.1101/gad.220202.113     Document Type: Article

References (35)

1. Ammirante M, Luo JL, Grivennikov S, Nedospasov S, Karin M. 2010. B-cell-derived lymphotoxin promotes castration-resistant prostate cancer. Nature 464: 302-305.
2. Beachy PA, Karhadkar SS, Berman DM. 2004. Tissue repair and stem cell renewal in carcinogenesis. Nature 432: 324-331.
3. Ben-Neriah Y, Karin M. 2011. Inflammation meets cancer, with NF-kB as the matchmaker. Nat Immunol 12: 715-723.
4. Cao Y, Bonizzi G, Seagroves TN, Greten FR, Johnson R, Schmidt EV, Karin M. 2001. IKKa provides an essential link between RANK signaling and cyclin D1 expression during mammary gland development. Cell 107: 763-775.
5. Chen J, Trounstine M, Alt FW, Young F, Kurahara C, Loring JF, Huszar D. 1993. Immunoglobulin gene rearrangement in B cell deficient mice generated by targeted deletion of the JH locus. Int Immunol 5: 647-656.
6. Dvorak HF. 1986. Tumors: Wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 315: 1650-1659.
7. English HF, Santen RJ, Isaacs JT. 1987. Response of glandular versus basal rat ventral prostatic epithelial cells to androgen withdrawal and replacement. Prostate 11: 229-242.
8. Greenberg NM, DeMayo F, Finegold MJ, Medina D, Tilley WD, Aspinall JO, Cunha GR, Donjacour AA, Matusik RJ, Rosen JM. 1995. Prostate cancer in a transgenic mouse. Proc Natl Acad Sci 92: 3439-3443.
9. Gulley J, Figg WD, Dahut WL. 2003. Treatment options for androgenindependent prostate cancer. Clin Adv Hematol Oncol 1: 49-57.
10. Guo WJ, Datta S, Band V, Dimri GP. 2007. Mel-18, a polycomb group protein, regulates cell proliferation and senescence via transcriptional repression of Bmi-1 and c-Myc oncoproteins. Mol Biol Cell 18: 536-546.
11. Hoberg JE, Popko AE, Ramsey CS, Mayo MW. 2006. IkB kinase a-mediated derepression of SMRT potentiates acetylation of RelA/p65 by p300. Mol Cell Biol 26: 457-471.
12. Hu Y, Baud V, Oga T, Kim KI, Yoshida K, Karin M. 2001. IKKa controls formation of the epidermis independently of NF-kB. Nature 410: 710-714.
13. Huang WC, Ju TK, Hung MC, Chen CC. 2007. Phosphorylation of CBP by IKKa promotes cell growth by switching the binding preference of CBP from p53 to NF-kB. Mol Cell 26: 75-87.
14. Ianari A, Gallo R, Palma M, Alesse E, Gulino A. 2004. Specific role for p300/CREB-binding protein-associated factor activity in E2F1 stabilization in response to DNA damage. J Biol Chem 279: 30830-30835.
15. Ivanova IA, Nakrieko KA, Dagnino L. 2009. Phosphorylation by p38 MAP kinase is required for E2F1 degradation and keratinocyte differentiation. Oncogene 28: 52-62.
16. Iyer NG, Ozdag H, Caldas C. 2004. p300/CBP and cancer. Oncogene 23: 4225-4231.
17. Jacobs JJ, Scheijen B, Voncken JW, Kieboom K, Berns A, van Lohuizen M. 1999. Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF. Genes Dev 13: 2678-2690.
18. Karhadkar SS, Bova GS, Abdallah N, Dhara S, Gardner D, Maitra A, Isaacs JT, Berman DM, Beachy PA. 2004. Hedgehog signalling in prostate regeneration, neoplasia and metastasis. Nature 431: 707-712.
19. Karin M. 2009. NF-kB as a critical link between inflammation and cancer. Cold Spring Harb Perspect Biol 1: a000141.
20. Kasper S. 2008. Exploring the origins of the normal prostate and prostate cancer stem cell. Stem Cell Rev 4: 193-201.
21. Kuraishy A, Karin M, Grivennikov SI. 2011. Tumor promotion via injuryand death-induced inflammation. Immunity 35: 467-477.
22. Lawson DA, Xin L, Lukacs RU, Cheng D, Witte ON. 2007. Isolation and functional characterization of murine prostate stem cells. Proc Natl Acad Sci 104: 181-186.
23. Lukacs RU, Memarzadeh S, Wu H, Witte ON. 2010. Bmi-1 is a crucial regulator of prostate stem cell self-renewal and malignant transformation. Cell Stem Cell 7: 682-693.
24. Luo JL, Tan W, Ricono JM, Korchynskyi O, Zhang M, Gonias SL, Cheresh DA, Karin M. 2007. Nuclear cytokine-activated IKKa controls prostate cancer metastasis by repressing Maspin. Nature 446: 690-694.
25. Maitland NJ, Collins AT. 2008. Prostate cancer stem cells: A new target for therapy. J Clin Oncol 26: 2862-2870.
26. Ohtani K, DeGregori J, Nevins JR. 1995. Regulation of the cyclin E gene by transcription factor E2F1. Proc Natl Acad Sci 92: 12146-12150.
27. Rahemtulla A, Fung-Leung WP, Schilham MW, Kundig TM, Sambhara SR, Narendran A, Arabian A, Wakeham A, Paige CJ, Zinkernagel RM, et al. 1991. Normal development and function of CD8+ cells but markedly decreased helper cell activity in mice lacking CD4. Nature 353: 180-184.
28. Siegel R, Naishadham D, Jemal A. 2012. Cancer statistics, 2012. CA Cancer J Clin 62: 10-29.
29. Sil AK, Maeda S, Sano Y, Roop DR, Karin M. 2004. IkB kinase-a acts in the epidermis to control skeletal and craniofacial morphogenesis. Nature 428: 660-664.
30. Trouche D, Kouzarides T. 1996. E2F1 and E1A(12S) have a homologous activation domain regulated by RB and CBP. Proc Natl Acad Sci 93: 1439-1442.
31. Tu Z, Prajapati S, Park KJ, Kelly NJ, Yamamoto Y, Gaynor RB. 2006. IKKa regulates estrogen-induced cell cycle progression by modulating E2F1 expression. J Biol Chem 281: 6699-6706.
32. Velnar T, Bailey T, Smrkolj V. 2009. The wound healing process: An overview of the cellular and molecular mechanisms. J Int Med Res 37: 1528-1542.
33. Wang H, Wang L, Erdjument-Bromage H, Vidal M, Tempst P, Jones RS, Zhang Y. 2004. Role of histone H2A ubiquitination in Polycomb silencing. Nature 431: 873-878.
34. Yamamoto Y, Verma UN, Prajapati S, Kwak YT, Gaynor RB. 2003. Histone H3 phosphorylation by IKK-a is critical for cytokine-induced gene expression. Nature 423: 655-659.
35. Zitvogel L, Kepp O, Kroemer G. 2010. Decoding cell death signals in inflammation and immunity. Cell 140: 798-804.